Are you Dr. Levine?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Nihncipob
9000 Rockville Pike 10CRC RM 1w3750
Bethesda, MD 20892Phone+1 301-594-2938Fax+1 301-451-7010
Summary
- Dr. Jason Levine, MD is a pediatric hematologist/oncologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland, Massachusetts, and New York. He is affiliated with Boston Children's Hospital.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Hematology/Oncology, 2003 - 2006
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2003
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
- MA State Medical License 2003 - 2026
- MD State Medical License 2006 - 2026
- NY State Medical License 2003 - 2005
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 6 citationsRelationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study.Elizabeth Vera, Alexa Christ, Ewa Grajkowska, Nicole Briceno, Anna Choi
Eclinicalmedicine. 2023-01-01 - 14 citationsThe Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.Joseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, David F Arons, Gregory J Aune
Journal of Clinical Oncology. 2023-08-20 - 3 citationsThe Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.Varna Jammula, James L Rogers, Elizabeth Vera, Alexa Christ, Heather E Leeper
Neuro-Oncology Practice. 2022-10-01